Open original FDA record ↗Recall record
- FDA identifier
- Z-1687-2016
- Company in FDA record
- Diamedix Corporation
- FDA record creation date
- May 16, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A gel-like substance was found in kit component, sample diluent , that could potentially compromise product performance.
Source facts
- Action
- The firm, Diamedix, sent letters dated October 14, October 20 and December 5, 2014 to its customers directly informing them of the correction action. Notification of all domestic customers via Certified Mail. Notification fo the international customers via Federal Express and/or e-mail. With the letter, a replacement bottle of Sample B Diluent was sent and the customer was advised to discard any unused bottles of affected product. New lot number labels were provided to identify kits with the replacement Sample B Diluent. Customers with questions were told they could contact Diamedix Technical Services (1-800-327-4565) if they had any questions or required any additional guidance regarding the correction.
- Initiated
- 2014-10-20
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2016-12-14
- Distribution
- Worldwide distribution: US nationwide including states of: AZ, CA, CO, FL, GA, IL, IN, KY, MA, MI, MO, NC, NE, NH, NJ, NY, OH, OK, OR, PA, RI, TN, TX, VA, WI and Puerto Rico. and Country of: ITALY.
- Recall number
- Z-1687-2016
- Recall status
- Terminated
- CDRH record ID
- 144776
- FDA record created
- 2016-05-16
- Recall event number
- 73694